![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
中东和非洲护理点分子诊断市场预测至 2028 年 - COVID-19 影响和按产品和服务(检测和试剂盒、仪器、服务和软件)、技术(PCR、等温核酸扩增技术( INAAT)和其他技术)、应用(传染病、肿瘤学、血液学、产前检测、内分泌学和其他应用)、最终用户(医院和诊所、诊断实验室、研究和学术机构等)
市场介绍
即时分子诊断包括便携式设备以及检测和分析;用于检测和诊断人类样本中疾病的试剂盒,例如咽拭子、血液、血清和粪便。分子诊断正在从集中实验室转向分散的护理点分子测试。由于其简单、方便、周转时间短以及改善患者治疗效果的潜力,POCT 正在迅速获得关注。
此外,对消耗特定病毒检测方法的需求不断增长及时控制感染的时间预计将在预测期内促进市场增长。
南非报告的 COVID-19 病例数是中东和非洲地区最高的,其次是沙特阿拉伯和阿联酋等。沙特政府的政策一直有利于国内制药企业的扩张;政府取消了原材料和中间产品的进口关税,并通过支持无息融资简化融资。同样,COVID-19 发病率的不断增加对其诊断中使用的试剂盒和试剂产生了巨大的需求。 2020年4月,中国基因组公司华大基因集团与阿联酋科技公司Group-42在阿联酋开设了一个新的大通量实验室,以支持新型冠状病毒的检测和诊断。华大基因表示,该实验室将使用已获得中国、欧洲、美国和日本医疗监管机构批准的RT-PCR诊断试剂盒。由于即时分子诊断试剂盒主要用于检测 SARS-CoV-2,此次疫情正在推动市场增长。
市场概况和动态
中东和中东地区非洲即时分子诊断市场预计将从 2021 年的 9400 万美元增至 2028 年的 2.129 亿美元。预计从 2021 年到 2028 年,该市场将以 12.4% 的复合年增长率增长。即时护理 (POC) 分子检测准确且可扩展,扩大了疾病诊断的范围,可以在社区和实验室之外进行。与实验室检测相比,即时分子诊断具有多种优势,例如更少的就诊次数、更短的住院时间、更好的药物治疗优化以及更少的不当药物使用。由于整个行业中新技术和有效技术的出现,医疗保健行业正在经历巨大的变革。因此,对比实验室测试花费更少时间的有效诊断的需求不断增长,推动了对 POC 分子检测和试剂盒的需求,从而推动了中东和中东地区的增长。预测期内非洲护理点分子诊断市场。
主要细分市场
在产品和服务方面服务方面,检测和试剂盒领域占据了中东和非洲地区的最大份额。 2020年非洲护理点分子诊断市场。就技术而言,PCR细分市场在中东和非洲地区占据最大份额。 2020年非洲床旁分子诊断市场。就应用而言,传染病领域占中东和非洲地区最大份额。 2020年非洲护理点分子诊断市场。就最终用户而言,诊断实验室领域占据中东和非洲地区的最大份额。 2020 年非洲护理点分子诊断市场。
主要来源和上市公司
准备本中东和中东地区护理点分子诊断市场报告时提到的一些主要一手和二手资料来源。非洲有公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括 BioMérieux SA、F. Hoffmann-La Roche Ltd.、Danaher Corporation、Enzo Biochem, Inc.、Abbott、Meridian BioScience, Inc.、Biocartis、Quidel Corporation 和 Bio-Rad Laboratories, Inc. .
购买原因报告
- 了解中东和中东地区非洲护理点分子诊断市场格局并确定可能保证丰厚回报的细分市场
- 了解不断变化的市场格局并在竞争中保持领先
- 有效规划中东和非洲地区的并购和合作交易。非洲护理点分子诊断市场,通过确定最有希望销售的细分市场
- 通过对各个细分市场的市场表现进行敏锐和全面的分析,做出明智的业务决策
- 获取中东及中东地区市场收入预测2021 年至 2028 年不同细分市场的非洲护理点分子诊断市场
中东和中东地区非洲护理点分子诊断市场细分
按产品和服务
- 检测和试剂盒
- 仪器
- 服务和软件
按技术
- PCR
- 等温核酸扩增技术(INAAT)
- 其他技术
作者应用
- 传染病
- 肿瘤学
- 血液学
- 产前检测
- 内分泌学
- 其他应用
作者最终用户
- 医院和诊所
- 诊断实验室
- 研究及学术机构
- 其他
按国家/地区
- 中东和中东地区非洲
- 阿联酋
- 沙特阿拉伯
- 南非
- 中东其他地区和地区非洲
提及的公司
- bioMérieux SA跨度>
- F.霍夫曼-拉罗氏有限公司
- 丹纳赫公司
- Enzo Biochem, Inc.
- 雅培
- Meridian BioScience, Inc.
- Biocartis
- Quidel 公司
- Bio-Rad Laboratories, Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Point-of-Care Molecular Diagnostics Market – By Product & Services
1.3.2 Middle East & Africa Point-of-Care Molecular Diagnostics Market – By Technology
1.3.3 Middle East & Africa Point-of-Care Molecular Diagnostics Market – By Application
1.3.4 Middle East & Africa Point-of-Care Molecular Diagnostics Market – By End User
1.3.5 Middle East & Africa Point-of-Care Molecular Diagnostics Market– By Geography
2. Middle East & Africa Point-of-Care Molecular Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Point-of-Care Molecular Diagnostics Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East & Africa – PEST Analysis
4.3 Experts Opinion
5. Point-of-Care Molecular Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Demand for Specific Viral Detection Methods that Consume Less Time for Timely Infection Control
5.1.2 Rising Incidences of Infectious Diseases
5.2 Market Restraints
5.2.1 Pricing Pressures owing to Reimbursement Cuts
5.3 Market Opportunities
5.3.1 Rising R&D and Innovation in Point-of-Care Molecular Diagnostics
5.4 Future Trends
5.4.1 Rising Implementation of Molecular Point-of-Care Diagnostic Devices and Kits across Residential Setting
5.5 Impact Analysis
6. Point-of-Care Molecular Diagnostics Market– Middle East & Africa Analysis
6.1 Middle East & Africa Point-of-Care Molecular Diagnostics Market Revenue Forecast and Analysis
7. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Product & services
7.1 Overview
7.2 Point-of-Care Molecular Diagnostics Market, by Product & services 2020 & 2028 (%)
7.3 Assays and Kits
7.3.1 Overview
7.3.2 Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Services and Software
7.5.1 Overview
7.5.2 Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Technology
8.1 Overview
8.2 Point-of-Care Molecular Diagnostics Market, by Technology 2020 & 2028 (%)
8.3 PCR
8.3.1 Overview
8.3.2 PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.4.1 Overview
8.4.2 Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Point-of-Care Molecular Diagnostics Market Analysis – By Application
9.1 Overview
9.2 Point-of-Care Molecular Diagnostics Market, by Application 2020 & 2028 (%)
9.3 Infectious Disease
9.3.1 Overview
9.3.2 Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Hematology
9.5.1 Overview
9.5.2 Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Prenatal Testing
9.6.1 Overview
9.6.2 Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Endocrinology
9.7.1 Overview
9.7.2 Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By End User
10.1 Overview
10.2 Point-of-Care Molecular Diagnostics Market, by End User 2020 & 2028 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Diagnostic Laboratories
10.4.1 Overview
10.4.2 Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Research and Academic Institutes
10.5.1 Overview
10.5.2 Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
11. Middle East & Africa Point-of-Care Molecular Diagnostics Market – Geographic Analysis
11.1 Middle East & Africa: Point-of-Care Molecular Diagnostics Market
11.1.1 Overview
11.1.2 Middle East & Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.3 Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By Product and Service, 2019-2028 (US$ Million)
11.1.4 Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By Technology, 2019-2028 (US$ Million)
11.1.5 Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By Application, 2019-2028 (US$ Million)
11.1.6 Middle East and Africa: Point-of-Care Molecular Diagnostics Market - By End User, 2019-2028 (US$ Million)
11.1.7 Middle East & Africa: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)
11.1.7.1 Saudi Arabia: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.1 Saudi Arabia: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.2 Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.1.7.1.3 Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.1.7.1.4 Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.1.7.1.5 Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.1.7.2 South Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.1 South Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.2 South Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.1.7.2.3 South Africa: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.1.7.2.4 South Africa: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.1.7.2.5 South Africa: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.1.7.3 UAE: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.1 UAE: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.2 UAE: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.1.7.3.3 UAE: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.1.7.3.4 UAE: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.1.7.3.5 UAE: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.1.7.4 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.4.1 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.4.2 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.1.7.4.3 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.1.7.4.4 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.1.7.4.5 Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
12. Impact Of COVID-19 Pandemic on Point-of-Care Molecular Diagnostics Market
12.1 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
13. Point-of-Care Molecular Diagnostics Market– Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 F. Hoffmann-La Roche Ltd.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 bioMérieux SA
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Abbott
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 MERIDIAN BIOSCIENCE, INC.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Enzo Biochem Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Biocartis
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Quidel Corporation
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Danaher
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 BIO-RAD LABORATORIES INC.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 2. Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 3. Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 4. Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 5. Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 6. Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 7. Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 8. Saudi Arabia: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 9. South Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 10. South Africa: Point-of-Care Molecular Diagnostics Market, By Technology - Revenue and Forecast to 2028 (US$ Million)
Table 11. South Africa: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 12. South Africa: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 13. UAE: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 14. UAE: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 15. UAE: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 16. UAE: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 19. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 20. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 21. Recent Organic Developments the Point-of-Care Molecular Diagnostics Market
Table 22. Recent Inorganic Developments in the Point-of-Care Molecular Diagnostics Market
Table 23. Glossary of Terms, Point-of-Care Molecular Diagnostics Market
LIST OF FIGURES
Figure 1. Point-of-Care Molecular Diagnostics Market Segmentation
Figure 2. Middle East & Africa Point-of-Care Molecular Diagnostics Market Overview
Figure 3. Assays and Kits Segment Held the Largest Share by Product & services in Middle East & Africa Point-of-Care Molecular Diagnostics Market
Figure 4. South Africa to Show Significant Growth During Forecast Period
Figure 5. Middle East & Africa Point-of-Care Molecular Diagnostics Market, Industry Landscape
Figure 6. Middle East & Africa PEST Analysis
Figure 7. Middle East & Africa Point-of-Care Molecular Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028
Figure 8. Point-of-Care Molecular Diagnostics Market, by Product & services 2020 & 2028 (%)
Figure 9. Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Point-of-Care Molecular Diagnostics Market, by Technology 2020 & 2028 (%)
Figure 13. PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Point-of-Care Molecular Diagnostics Market, by Application 2020 & 2028 (%)
Figure 17. Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Point-of-Care Molecular Diagnostics Market, by End User 2020 & 2028 (%)
Figure 24. Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Middle East & Africa: Point-of-Care Molecular Diagnostics Market, by Key Country- Revenue (2021) (US$ Million)
Figure 29. Middle East & Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Middle East & Africa: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)
Figure 31. Saudi Arabia: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. South Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. UAE: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. Rest of Middle East and Africa: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 35. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in Middle East & Africa
Figure 36. Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021
- bioMérieux SA
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Enzo Biochem, Inc.
- Abbott
- Meridian BioScience, Inc.
- Biocartis
- Quidel Corporation
- Bio-Rad Laboratories, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa Point-of-Care molecular diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa Point-of-Care molecular diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.